Laboratory biomarker predictors for disease progression and outcome among Egyptian COVID-19 patients
이집트 COVID-19 환자의 질병 진행 및 결과에 대한 실험실 바이오마커 예측자
Article
Published on
Journal: International journal of immunopathology and pharm
[Category] SARS, 바이오마커, 치료기술,
Journal: International journal of immunopathology and pharm
[Category] SARS, 바이오마커, 치료기술,
[키워드] acute respiratory syndrome
acute respiratory syndrome coronavirus
acute respiratory syndrome coronavirus 2
addition
Admission
Alanine
alanine aminotransferase
ALT
Biomarker
Biomarkers
blood cell
C-reactive protein
changes in
Chest computed tomography
Clinical characteristics
Clinical deterioration
Clinical outcome
clinical outcomes
Computed tomography
Consequences
coronavirus
coronavirus disease
correlation
COVID-19
COVID-19 patient
creatinine
D-dimer
death
diabete
diabetes
Disease progression
disease severity
examined
FIVE
help
high-risk patient
High-risk patients
highly sensitive C-reactive protein
hs-CRP
hypertension
identify
Increased
increased respiratory rate
infected case
Laboratory
laboratory biomarkers
laboratory findings
laboratory-confirmed
Lactate
lactate dehydrogenase
LDH
lymphocyte
lymphopenia
Mild
moderate
Mortality
neutrophil
neutrophil lymphocyte ratio
neutrophil lymphocyte ratio and lactate dehydrogenase.
neutrophilia
NLR
outcome
pandemic
Patient
physician
Platelet
Platelet count
predict
predictor
prognostic indicator
respiratory
respiratory rate
risk factor
SARS-CoV-2
SARS-COV-2 infection
secondary to
severe acute respiratory syndrome Coronavirus
severe cases
severity
the disease
White blood cell
white blood cell count
[DOI] 10.1177/03946320221096207 PMC 바로가기 [Article Type] Article
[DOI] 10.1177/03946320221096207 PMC 바로가기 [Article Type] Article